moderate to strong reactivity ( 2-3+ ) was seen in six of nine normal secretory endometria ( 67 % ) , one of 10 normal proliferative endometria ( 10 % ) , 18 of 18 endometrial adenocarcinomas ( 100 % ) , 10 of 11 endometrioid ovarian adenocarcinomas ( 91 % ) , seven of nine clear cell ovarian adenocarcinomas ( 78 % ) , one of 12 endometrial hyperplasias without atypia ( 9 % ) , two of four endometrial hyperplasias with atypia ( 50 % ) , zero of five endometrial serous adenocarcinomas , two of 17 serous ovarian adenocarcinomas ( 12 % ) , zero of 10 intestinal-type mucinous ovarian adenocarcinomas , and zero of nine metastatic adenocarcinomas in ovary .
C1335177
serous ovarian adenocarcinomas
C0029939
ovary